Interleukin-5 Antagonist [EPC] - N0000191872

Pharmacologic Class Information

Pharmacologic Code N0000191872
Pharmacologic Name Interleukin-5 Antagonist
Pharmacologic Uses
  • interleukin-5 antagonist
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Interleukin-5 Antagonist

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Interleukin-5 Antagonist [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0173-0881Nucala Non-Proprietary Name: MepolizumabInjection, Powder, For SolutionSubcutaneousGlaxosmithkline LlcACTIVE
0173-0892Nucala Non-Proprietary Name: MepolizumabInjection, SolutionSubcutaneousGlaxosmithkline LlcACTIVE
0173-0904Nucala Non-Proprietary Name: MepolizumabInjection, SolutionSubcutaneousGlaxosmithkline LlcACTIVE
59310-610Cinqair Non-Proprietary Name: ReslizumabInjection, Solution, ConcentrateIntravenousTeva Respiratory, LlcACTIVE